Omental milky spots in screening gastric cancer stem cells

Neoplasma

Volumn 58, Issue 1, 2011, Pages 20-26

  Cao, L ^a   Hu, X ^a   Zhang, Y ^a   Sun, X T ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; Gastric cancer; Omental milky spot; Omentum

Indexed keywords

ANTIGEN; CD133 ANTIGEN; CD324 ANTIGEN; UNCLASSIFIED DRUG; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER SCREENING; CANCER STEM CELL; CELL ADHESION; CONTROLLED STUDY; CYTOTOXICITY; LYMPHOID TISSUE; MACROPHAGE; MOUSE; NONHUMAN; OMENTUM MILKY SPOT; PERITONEUM METASTASIS; STOMACH CANCER; ANIMAL; METASTASIS; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; OMENTUM; PATHOLOGY; PERITONEUM TUMOR; STOMACH TUMOR;

ANIMALS; ANTIGENS, CD; GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; OMENTUM; PEPTIDES; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS;

EID: 79961105556     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_01_20     Document Type: Article

References (24)

1. REYA T, MORRISON SJ, CLARKE MF, WEISSMAN IL.: Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11. doi:10.1038/35102167.
2. SOLTYSOVA A, ALTANEROVA V, ALTANER C.: Cancer stem cells minireview. Neoplasma 2005; 52 435-440.
3. TAKAHASHI T, SAIKAWA Y, NAKAMURA R, KUMAGAI K, TAKEUCHI H et al.: Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines. Oncol Rep. 2009; 21: 451-59.
4. HARRIS MA, YANG H, LOW BE, MUKHERJEE J, GUHA A et al.: Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 2008; 68: 10051-9. doi:10.1158/0008-5472.CAN-08-0786.
5. TSUJIMOTO H, HAGIWARA A, SHIMOTSUMA M, SAKAKURA C, OSAKI K et al.: Role of milky spots as selective implantation sites for malignant cells in peritoneal dissemination in mice. J Cancer Res Clin Oncol 1996; 122: 590-5. doi:10.1007/BF01221190.
6. BERBERICH S, DÄHNE S, SCHIPPERS A, PETERS T, MULLER W et al.: Differential molecular and anatomical basis for B cell migration into the peritoneal cavity and omental milky spots. J Immunol. 2008; 15: 2196-203.
7. OOSTERLING SJ., VAN DER BIJ GJ, BOGELS M, van der SIJP JR, Beelen RH et al.: Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease. Cancer Immunol Immunother 2006; 55: 1043-51. doi:10.1007/s00262-005-0101-y.
8. CUI L, JOHKURA K, LIANG Y, TENG R, OGIWARA N et al.: Biodefense function of omental milky spots through cell adhesion molecules and leukocyte proliferation. Cell Tissue Res 2002; 310: 321-30. doi:10.1007/s00441-002-0636-6.
9. ELIZABETH WS, SCOTT AG, ABIGAIL LS, RYBALKO VY, CHAN WM et al.: Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunol Res 2009; 45: 185-94. doi:10.1007/s12026-009-8100-2.
10. SCOTT AG, VIKTORIYA YR, CHAD EB, LUGADE AA, FOSTER TH et al.: Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. The American Journal of Pathology, 2006; 169: 1739-52 doi:10.2353/ajpath.2006.051222.
11. NATALIA OL, KRISHNAMURTHY PG, PERIANNA S, ARRUDA JA, DUNEA G et al.: Activated omentum becomes rich in factors that promote healing and tissue regeneration. Cell Tissue Res,2007; 328: 487-97. doi:10.1007/s00441-006-0356-4.
12. BRUCE MB, HELEN F.: Cancer stem cells: A step toward the cure. Nature 2008; 26: 2795-9.
13. CATHERINE AO, AARON P, STEVEN G, DICK JE.: A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007; 445: 106-10. doi:10.1038/nature05372.
14. BONNET D, DICK JE.: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-7. doi:10.1038/nm0797-730.
15. PONTI D, COSTA A, ZAFFARONI N, PRATESI G, PETRANGOLINI G et al.: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506-11. doi:10.1158/0008-5472.CAN-05-0626.
16. SINGH SK, HAWKINS C, CLARKE ID, SQUIRE JA, BAYANI J et al.: Identification of human brain tumor initiating cells. Nature 2004; 432: 396-401. doi:10.1038/nature03128.
17. PRINCE ME, SIVANANDAN R, KACZOROWSKI A, WOLF GT, KAPLAN MJ et al.: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. PNAS 2007; 104: 973-8. doi:10.1073/pnas.0610117104.
18. PATRAWALA L, CALHOUN T, SCHNEIDER BR, LI H, BHATIA B et al.: Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-708. doi:10.1038/sj.onc.1209327.
19. MA S, LEE TK, ZHENG BJ, CHAN KW, GUAN XY.: CD133 HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008; 27: 1749-58. doi:10.1038/sj.onc.1210811.
20. LI C, HEIDT DG, DALERBA P, BURANT CF, ZHANG L et al.: Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-7. doi:10.1158/0008-5472.CAN-06-2030.
21. SHIGEHIRO Y, SHOJI N, YOSHIKAZU U.: Sentinel node micrometastases have high proliferative potential in gastric cancer. J Sur Res 2008; 145: 238-43. doi:10.1016/j.jss.2007.04.037.
22. JAMES AK, FRÉDÉRIC B, ARMANDO G. POEPPL, WANG JC, DICK JE.: Comment on "Tumor growth need not be driven by rare cancer stem cells. Science 2007; 318: 1722.
23. VINCENT Z, NORBERT B, STÉPHANE M, LAPIERRE V, TIBERGHIEN P et al.: Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner. Stem cells and development 2008; 17: 1005-16. doi:10.1089/scd.2007.0248.
24. SANTIS GD, MIOTTI S, MAZZI M, CANEVARI S, TOMASSETTI A.: E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adhere junctions of ovarian carcinoma cells. Oncogene 2009;28: 1206-17. doi:10.1038/onc.2008.470.